Quinn Lu

机构：GlaxoSmithKline (United States) · ORCID：0000-0002-2093-6063

发表论文 47 篇 · 总被引 2069 次 · h-index 22

代表论文

• Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway (1999 · Oncogene · 被引 424)
• A search for proteins that interact genetically with histone H3 and H4 amino termini uncovers novel regulators of the Swe1 kinase in Saccharomyces cerevisiae. (1996 · Genes & Development · 被引 178)
• Architectural variations of inducible eukaryotic promoters: Preset and remodeling chromatin structures (1994 · BioEssays · 被引 161)
• Seamless cloning and gene fusion (2005 · Trends in biotechnology · 被引 123)
• Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments (2018 · Journal of Biotechnology · 被引 99)
• Nucleosome positioning and gene regulation (1994 · Journal of Cellular Biochemistry · 被引 84)